Connection

Brent Egan to Time Factors

Back to Details
This is a "connection" page, showing publications Brent Egan has written about Time Factors.
Brent Egan
Connection Strength
0.415
Time Factors
  1. Cholesterol Control Among Uninsured Adults Did Not Improve From 2001-2004 to 2009-2012 as Disparities With Both Publicly and Privately Insured Adults Doubled. J Am Heart Assoc. 2017 Nov 02; 6(11).
    View in: PubMed
    Score: 0.084
  2. Initial monotherapy and combination therapy and hypertension control the first year. Hypertension. 2012 Jun; 59(6):1124-31.
    View in: PubMed
    Score: 0.057
  3. Prehypertension: risk stratification and management considerations. Curr Hypertens Rep. 2008 Oct; 10(5):359-66.
    View in: PubMed
    Score: 0.045
  4. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens. 2002 Jun; 20(6):1215-21.
    View in: PubMed
    Score: 0.029
  5. Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins. Hypertension. 2001 Oct; 38(4):858-63.
    View in: PubMed
    Score: 0.027
  6. Efficacy of a church-based intervention on cardiovascular risk reduction. Ethn Dis. 2001; 11(4):817-22.
    View in: PubMed
    Score: 0.026
  7. Five-year follow-up of patients treated with intra-dermal botulinum toxin for axillary hyperhidrosis. Ir J Med Sci. 2020 Aug; 189(3):1023-1026.
    View in: PubMed
    Score: 0.024
  8. Relationship between risk factor control and vascular events in the SAMMPRIS trial. Neurology. 2017 Jan 24; 88(4):379-385.
    View in: PubMed
    Score: 0.020
  9. Longitudinal assessment of von Willebrand factor antigen and von Willebrand factor propeptide in response to alteration of antiplatelet therapy after TIA or ischaemic stroke. J Neurol. 2014 Jul; 261(7):1405-12.
    View in: PubMed
    Score: 0.016
  10. Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects. J Hum Hypertens. 1994 Jan; 8(1):59-64.
    View in: PubMed
    Score: 0.016
  11. Increased platelet activation in early symptomatic vs. asymptomatic carotid stenosis and relationship with microembolic status: results from the Platelets and Carotid Stenosis Study. J Thromb Haemost. 2013 Jul; 11(7):1407-16.
    View in: PubMed
    Score: 0.016
  12. Similar blood pressure values across racial and economic groups: baseline data from a group randomized clinical trial. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):404-12.
    View in: PubMed
    Score: 0.015
  13. Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens. 1991 May; 4(5 Pt 1):416-21.
    View in: PubMed
    Score: 0.013
  14. Comparative efficacy of aliskiren monotherapy and ramipril monotherapy in patients with stage 2 systolic hypertension: subgroup analysis of a double-blind, active comparator trial. Cardiovasc Ther. 2010 Dec; 28(6):344-9.
    View in: PubMed
    Score: 0.013
  15. Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial. J Hypertens. 2008 Mar; 26(3):589-99.
    View in: PubMed
    Score: 0.011
  16. Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch. J Clin Endocrinol Metab. 1989 Apr; 68(4):735-9.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.